The Leader in Detecting Ocular Biomarkers for Diseases of the Eye, Heart, and Brain
Alzheimer’s Disease Trial
Amydis is developing an eye test that can label and detect amyloid in the retina. This test could help doctors diagnose and monitor AD, and potentially catch the disease early by a simple, low-cost eye scan.
Cerebral Amyloid Angiopathy Trial
With the help of Amydis’ non-invasive eye test, early diagnosis of CAA may be possible, enabling the opportunity for improved patient care by detecting diseases earlier when they can be most effectively treated.
Who to contact regarding possible participation?
Enrolled participants will receive a stipend.
Dr. David Wirta
Eye Research Foundation, Inc.
520 Superior Avenue, Suite #235
Newport Beach, CA 92663
Attn: Linda Wirta 949-650-1863
Email: linda.wirta@drwirta.com
Dr. Benjamin Bakall
Associated Retina Consultants
1750 E. Glendale Ave
Phoenix, AZ 85020
Attn: Mallory Mintert 480-999-5458
Email: mallory.mintert@doctrials.com
Dr. Sherif El-Harazi
Global Research Management
1510 S Central Ave #300
Glendale, CA 91204
Attn: Logi El-Harazi 818-246-2560
Email: logi@grmclinical.com